Arxis (ARXS) Registration filing summary

Company overview and business model

• Designer and manufacturer of proprietary, mission-critical electronic and mechanical components for extreme environments; portfolio spans defense and space, commercial aerospace, medical technology and specialized industrial applications.

• Two segments: Electronic Components (43% of revenue in H1 2026; connectors, cable assemblies, sensors and related products) and Mechanical Components (57%; bearings, seals, springs, gaskets and radar-absorbing materials).

• “Layer cake” model comprises 11,000+ part-customer-platform combinations; designed-in products can remain in production for 20+ years and in service for 40+ years, supporting recurring build-rate and aftermarket revenue.

• Decentralized operations use Arxis EDGE real-time analytics and cross-functional selling to pursue new platform wins, cross-sell and manage pricing; 37 acquisitions completed since 2019.

• Operates 78 manufacturing facilities across North America, Europe and Asia; approximately 6,800 employees as of September 30, 2026.

Financial performance and metrics

• H1 2026 revenue was $959,586k vs. $780,523k H1 2025; organic revenue rose 19.1%, including a 1% favorable FX impact, and acquisition revenue was $30,062k.

• H1 2026 gross profit was $497,444k and gross margin 51.8%, vs. $360,525k and 46.2% H1 2025; higher volume, price realization and operating execution supported expansion.

• H1 2026 net income was $48,400k vs. net loss of $33,580k H1 2025; Adjusted EBITDA was $386,693k vs. $287,799k, with margins of 40.3% and 36.9%, respectively.

• FY 2025 revenue was $1,591,020k vs. $742,992k FY 2024; organic revenue grew 8.9%, while acquisition revenue was $782,253k.

• June 30, 2026 cash was $494,693k; debt was $1,733,660k gross and $1,718,018k noncurrent, with $396,284k available on the revolver; operating cash flow H1 2026 was $174,354k.

Use of proceeds and capital allocation

• No proceeds from the registered resale will go to the issuer; selling holders receive proceeds from any shares sold.

• Proceeds from the April 2026 IPO were $1,220,603k net; $946,000k repaid term-loan debt, with the remainder allocated to working capital and general corporate purposes.

• Capital allocation priorities include acquisitions, capital expenditures, working capital and debt service; management expected operating cash flow and available credit to fund needs for at least the next 12 months as of June 30, 2026.

• No cash dividends are anticipated in the foreseeable future; available funds and future earnings are intended to support business development and expansion.